Here is a thorough breakdown of what the evidence says:
Vicks VapoRub in Children: Efficacy, Safety, and Contraindications
What's in it?
Vicks VapoRub contains three active ingredients:
- Camphor (4.8%) - a counterirritant
- Menthol (2.6%) - decongestant/cough suppressant sensation
- Eucalyptus oil (1.2%) - counterirritant
Does it actually work?
The short answer is: probably not in a meaningful clinical sense, and the "relief" may be illusory.
- Menthol and the other ingredients create a cold, tingly sensation that activates cold-receptor neurons (TRPM8 channels), making people feel like their airways are more open - but objective airflow measurements show no actual bronchodilation or decongestion.
- A 2009 study of 138 children (the most-cited supportive trial) found that parents reported symptom improvement when Vicks was applied to chest/neck vs. petroleum jelly or nothing - but this is a parent-reported, single study, and is far from robust evidence.
- The University of Maryland emergency medicine review states plainly: there is no data to support efficacy, and studies have shown increased airflow resistance with application in some cases.
Contraindications and Safety Concerns
Hard contraindication: Under 2 years of age
The product label and the American Academy of Pediatrics (AAP) state clearly that Vicks VapoRub must not be used in children under 2. Procter & Gamble (the manufacturer) also carries this warning.
Why under-2s are at highest risk:
- Infant airways are much narrower than adult airways
- The camphor/menthol/eucalyptus combination can act as an irritant, triggering increased mucus production
- This can dangerously worsen already narrowed infant airways
- A published case report describes an 18-month-old developing severe respiratory distress after Vicks was applied under her nose
Never apply to or near the nostrils (any age) - this is explicitly stated on the label and has caused emergency presentations.
Toxicity Profile
| Ingredient | Toxic Effect if Misused |
|---|
| Camphor | Ingestion causes nausea, vomiting, seizures, CNS toxicity, and death; especially dangerous in young children who may ingest it |
| Menthol | Aspiration, apnea, laryngoconstriction if applied to mucosa or ingested |
| Eucalyptus oil | CNS depression, seizures if ingested |
Documented case examples:
- A 3-year-old with epilepsy had a 9-minute seizure after prolonged chest/forehead/back application combined with camphor vaporizer use - seizures stopped after camphor was removed.
- A 4-year-old who ate ~2 oz of VapoRub developed vomiting and seizures hours later.
- A cluster of childhood seizures linked to camphor poisoning was reported in Pediatrics (Khine et al., 2009).
Summary of Contraindications
| Situation | Guidance |
|---|
| Children under 2 | Contraindicated - manufacturer warning, AAP guidance |
| Application to nostrils/face | Contraindicated at any age |
| Ingestion | Toxic at any age; camphor is especially dangerous in children |
| Eye contact | Can cause corneal damage and permanent vision loss |
| Broken/damaged skin | Avoid - increased absorption risk |
| Children with seizure disorders | Use with extreme caution - camphor lowers seizure threshold |
| Chest application during breastfeeding | Avoid - infant may ingest via skin contact |
Bottom Line
For children aged 2 and older, Vicks VapoRub applied to the chest and throat per label directions is generally considered safe for short-term use, though the evidence for actual efficacy is weak. The perceived relief is largely a sensory illusion from cold-receptor stimulation, not true decongestion.
For children under 2, it is contraindicated. Parents seeking congestion relief for infants should discuss alternatives (saline drops, bulb suctioning, humidifiers) with their pediatrician rather than reaching for VapoRub.